119 related articles for article (PubMed ID: 20175823)
21. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.
Buechler C; Ritter M; Orsó E; Langmann T; Klucken J; Schmitz G
J Leukoc Biol; 2000 Jan; 67(1):97-103. PubMed ID: 10648003
[TBL] [Abstract][Full Text] [Related]
22. Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.
Amador-Ortiz C; Hurley MY; Ghahramani GK; Frisch S; Klco JM; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
J Cutan Pathol; 2011 Dec; 38(12):945-53. PubMed ID: 22050091
[TBL] [Abstract][Full Text] [Related]
23. Leu-M1 antigen as a marker of acute nonlymphoid leukemia.
Chan J; Beckstead JH
Hematol Pathol; 1987; 1(4):209-15. PubMed ID: 2461928
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors.
Weaver LK; Pioli PA; Wardwell K; Vogel SN; Guyre PM
J Leukoc Biol; 2007 Mar; 81(3):663-71. PubMed ID: 17164428
[TBL] [Abstract][Full Text] [Related]
25. Leukemia cutis.
Babina T; Miller L; Thomas B
J Drugs Dermatol; 2012 Mar; 11(3):416-7. PubMed ID: 22395597
[No Abstract] [Full Text] [Related]
26. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
[TBL] [Abstract][Full Text] [Related]
27. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.
Fonseca JE; Edwards JC; Blades S; Goulding NJ
Arthritis Rheum; 2002 May; 46(5):1210-6. PubMed ID: 12115225
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.
Cruse JM; Lewis RE; Pierce S; Lam J; Tadros Y
Exp Mol Pathol; 2005 Aug; 79(1):39-41. PubMed ID: 16005710
[TBL] [Abstract][Full Text] [Related]
29. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
[TBL] [Abstract][Full Text] [Related]
30. Cytophagic and S-100 protein immunoreactive myeloid leukemia cutis.
Thomas CG; Patel RM; Bergfeld WF
J Cutan Pathol; 2010 Mar; 37(3):390-5. PubMed ID: 19615019
[TBL] [Abstract][Full Text] [Related]
31. Podocalyxin is expressed in normal and leukemic monocytes.
Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
[TBL] [Abstract][Full Text] [Related]
32. Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163.
Sulahian TH; Pioli PA; Wardwell K; Guyre PM
J Leukoc Biol; 2004 Jul; 76(1):271-7. PubMed ID: 15075364
[TBL] [Abstract][Full Text] [Related]
33. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy.
Van Gorp H; Delputte PL; Nauwynck HJ
Mol Immunol; 2010 Apr; 47(7-8):1650-60. PubMed ID: 20299103
[TBL] [Abstract][Full Text] [Related]
34. An updated approach to the diagnosis of myeloid leukemia cutis.
Cronin DM; George TI; Sundram UN
Am J Clin Pathol; 2009 Jul; 132(1):101-10. PubMed ID: 19864240
[TBL] [Abstract][Full Text] [Related]
35. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.
Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK
Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020
[TBL] [Abstract][Full Text] [Related]
36. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
37. Monocyte/Macrophage-specific marker CD163+ histiocytic sarcoma: case report with clinical, morphologic, immunohistochemical, and molecular genetic studies.
Mikami M; Sadahira Y; Suetsugu Y; Wada H; Sugihara T
Int J Hematol; 2004 Nov; 80(4):365-9. PubMed ID: 15615263
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes.
Timmermann M; Högger P
Free Radic Biol Med; 2005 Jul; 39(1):98-107. PubMed ID: 15925282
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow.
Chang CC; Eshoa C; Kampalath B; Shidham VB; Perkins S
Am J Clin Pathol; 2000 Nov; 114(5):807-11. PubMed ID: 11068557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
